Center for Addiction Medicine

CAM fNIRS Study Featured on Boston Globe’s Front Page

The Boston Globe’s front page on February 5, 2022 featured CAM Founding Director Dr. Eden Evins’s and Director of Neuroscience Dr. Jodi Gilman’s efforts to develop a device to reliably detect marijuana impairment. The device uses functional near-infrared spectroscopy, or fNIRS, to look into the brain using light-based imaging. Because the brain looks different when an individual is intoxicated, fNIRS was shown to be able to reliably tell the difference between people who are actually impaired by marijuana and those who simply used it recently. Evins and Gilman believe that this technology could lead to a roadside device that can identify impaired drivers more accurately than methods that measure THC levels in the blood or saliva.

Read the full article at this link, or view the PDF. If you are interested in learning more about fNIRS, please watch PBS NewsHour’s 2018 video featuring Dr. Gilman: